{"result": {"id": "4bf041a9-8938-4513-b60f-4b4a27096ffe", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>ANTI-ANXIETY/DEPRESSION DRUGS<|>ORGANIZATION<|>A class of drugs that can interact with certain blood pressure medications\")\n##\n(\"entity\"<|>BLOOD PRESSURE MEDICATIONS<|>ORGANIZATION<|>A class of medications used to treat hypertension\")\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>A medical condition characterized by high blood pressure\")\n##\n(\"entity\"<|>CARDIOVASCULAR COMPLICATIONS<|>EVENT<|>Health issues related to the heart and blood vessels\")\n##\n(\"entity\"<|>RANDOMIZED CONTROLLED TRIALS<|>EVENT<|>Clinical studies that provide evidence for hypertension treatment\")\n##\n(\"relationship\"<|>ANTI-ANXIETY/DEPRESSION DRUGS<|>NIFEDIPINE<|>Anti-anxiety/depression drugs can increase the concentration of Nifedipine<|>8)\n##\n(\"relationship\"<|>ANTI-ANXIETY/DEPRESSION DRUGS<|>VERAPAMIL<|>Anti-anxiety/depression drugs can increase the concentration of Verapamil<|>8)\n##\n(\"relationship\"<|>ANTI-ANXIETY/DEPRESSION DRUGS<|>METOPROLOL<|>Anti-anxiety/depression drugs can increase the concentration of Metoprolol<|>8)\n##\n(\"relationship\"<|>BLOOD PRESSURE MEDICATIONS<|>HYPERTENSION<|>Blood pressure medications are used to treat hypertension<|>9)\n##\n(\"relationship\"<|>HYPERTENSION<|>CARDIOVASCULAR COMPLICATIONS<|>Hypertension can lead to cardiovascular complications<|>8)\n##\n(\"relationship\"<|>RANDOMIZED CONTROLLED TRIALS<|>HYPERTENSION<|>Randomized controlled trials provide evidence for hypertension treatment<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558642, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 445, "prompt_tokens": 3436, "total_tokens": 3881, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2624}, "prompt_cache_hit_tokens": 2624, "prompt_cache_miss_tokens": 812}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 上  从事与睡眠不相关的刺激性活动(如看电视、玩手机、 阅读、做计划/思考等) 。③睡眠限制疗法 ,控制白天睡  眠时间不宜过长 。催眠疗法、物理治疗、中医治疗对于  改善睡眠障碍也有一定的作用。\n　　　(3)必要时进行药物治疗 。注意降压药和睡眠药 物的相互作用[198]  : ①抗焦虑/抑郁药可升高硝苯地 平、维拉帕米、美托洛尔的药物浓度 ,应选择舍曲林、西 酞普兰等相互作用小的药物 ;②曲唑酮、米氮平和文拉 法新可导致体位性低血压 ,应注意用药剂量并在睡前 服用。\n5.2.2  高血压的药物治疗\n\n要点 5E   高血压的药物治疗\n　　　· 常用的降压药均可作为初始治疗用药 ,建议根 据特殊人群的类型、合并症选择针对性的药物 ,进行 个体化治疗( Ⅰ ,A) 。\n　　　·应根据血压水平和心血管风险选择初始单药 或联合治疗( Ⅰ ,A) 。\n　　　·一般患者采用常规剂量 ;衰弱和高龄老年人初  始治疗时通常应采用较小的有效治疗剂量( Ⅰ , C) 。 根据需要 ,可考虑逐渐增加至足剂量( Ⅱb,C) 。\n　　　·优先使用长效降压药 , 以有效控制 24h血压 , 更有效预防心脑血管并发症( Ⅰ ,A) 。\n　　　· 血压 ≥160/100 mmHg,高于 目标血压 20/ 10mmHg的高危/很高危患者 , 或单药治疗未达标  的高血压患者应进行联合降压治疗 ,包括自由联合或  单片复方制剂( Ⅰ ,A) 。\n　　　·对血压 ≥140/90mmHg的患者 ,也可起始小 剂量联合治疗( Ⅱb,B) 。\n\n　　　生活方式干预无疑可以降低血压 ,并在某些情况 下降低心血管风险 ,但大多数高血压患者以及部分心 血管风险高危的正常高值者仍然需要药物治疗 。一系 列基于结局的临床随机对照试验为高血压的药物治疗 提供了可靠的证据。\n　5.2.2.1   降压治疗的临床试验证据    自 20世纪 50 年代以来 ,在全世界范围内进行了以心脑血管并发症  为主要研究目标的随机对照的降压治疗临床试验 ,为  高血压的治疗与管理建立了理论基础 。这些临床试验  可分为 4种情况 :\n\n\n\n　　　(1)安慰剂对比的临床试验 。较早期的降压治疗 试验 ,主要对比研究降压治疗与安慰剂或不治疗 ,结果 显示降压治疗可以显著降低各种类型的高血压患者发 生心脑血管并发症的风险 。这些研究是治疗与管理各 种类型的高血压最重要\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>SLEEP RESTRICTION THERAPY<|>EVENT<|>A therapy that controls daytime sleep time to improve sleep disorders\")\n##\n(\"entity\"<|>HYPNOTHERAPY<|>EVENT<|>A therapy used to improve sleep disorders\")\n##\n(\"entity\"<|>PHYSICAL THERAPY<|>EVENT<|>A therapy used to improve sleep disorders\")\n##\n(\"entity\"<|>TRADITIONAL CHINESE MEDICINE TREATMENT<|>EVENT<|>A therapy used to improve sleep disorders\")\n##\n(\"entity\"<|>NIFEDIPINE<|>PERSON<|>A drug whose concentration can be increased by anti-anxiety/depression drugs\")\n##\n(\"entity\"<|>VERAPAMIL<|>PERSON<|>A drug whose concentration can be increased by anti-anxiety/depression drugs\")\n##\n(\"entity\"<|>METOPROLOL<|>PERSON<|>A drug whose concentration can be increased by anti-anxiety/depression drugs\")\n##\n(\"entity\"<|>SERTRALINE<|>PERSON<|>A drug with small interactions, recommended for use with certain medications\")\n##\n(\"entity\"<|>CITALOPRAM<|>PERSON<|>A drug with small interactions, recommended for use with certain medications\")\n##\n(\"entity\"<|>TRAZODONE<|>PERSON<|>A drug that can cause orthostatic hypotension\")\n##\n(\"entity\"<|>MIRTAZAPINE<|>PERSON<|>A drug that can cause orthostatic hypotension\")\n##\n(\"entity\"<|>VENLAFAXINE<|>PERSON<|>A drug that can cause orthostatic hypotension\")\n##\n(\"relationship\"<|>SLEEP RESTRICTION THERAPY<|>HYPNOTHERAPY<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>SLEEP RESTRICTION THERAPY<|>PHYSICAL THERAPY<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>SLEEP RESTRICTION THERAPY<|>TRADITIONAL CHINESE MEDICINE TREATMENT<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>HYPNOTHERAPY<|>PHYSICAL THERAPY<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>HYPNOTHERAPY<|>TRADITIONAL CHINESE MEDICINE TREATMENT<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>PHYSICAL THERAPY<|>TRADITIONAL CHINESE MEDICINE TREATMENT<|>Both are therapies used to improve sleep disorders<|>5)\n##\n(\"relationship\"<|>NIFEDIPINE<|>SERTRALINE<|>Sertraline is recommended for use with Nifedipine due to small interactions<|>7)\n##\n(\"relationship\"<|>NIFEDIPINE<|>CITALOPRAM<|>Citalopram is recommended for use with Nifedipine due to small interactions<|>7)\n##\n(\"relationship\"<|>VERAPAMIL<|>SERTRALINE<|>Sertraline is recommended for use with Verapamil due to small interactions<|>7)\n##\n(\"relationship\"<|>VERAPAMIL<|>CITALOPRAM<|>Citalopram is recommended for use with Verapamil due to small interactions<|>7)\n##\n(\"relationship\"<|>METOPROLOL<|>SERTRALINE<|>Sertraline is recommended for use with Metoprolol due to small interactions<|>7)\n##\n(\"relationship\"<|>METOPROLOL<|>CITALOPRAM<|>Citalopram is recommended for use with Metoprolol due to small interactions<|>7)\n##\n(\"relationship\"<|>TRAZODONE<|>MIRTAZAPINE<|>Both can cause orthostatic hypotension<|>6)\n##\n(\"relationship\"<|>TRAZODONE<|>VENLAFAXINE<|>Both can cause orthostatic hypotension<|>6)\n##\n(\"relationship\"<|>MIRTAZAPINE<|>VENLAFAXINE<|>Both can cause orthostatic hypotension<|>6)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_4d9a3882c20b563abcacf7c831021cb525f2467fc940afb531dc6db721c29898_v2"}